Immuno - Oncology

 The use of the immune system to treat cancer. Immunotherapies can be categorized as active, passive or hybrid (active and passive). These tactics exploit the fact that cancer cells repeatedly have molecules on their surface that can be noticed by the immune system, identified as tumour-associated antigens they are often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the immune system to attack tumour cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumour responses and comprise the use of monoclonal antibodies, lymphocytes and cytokines.

  • Track 1-1 Targeted & conventional radiotherapy
  • Track 2-2 Chemo therapy
  • Track 3-3 Targeted therapy
  • Track 4-4 Radiation therapy
  • Track 5-5 Cancer immunotherapy

Related Conference of Immunology